［1］ LENEVA I A， FEDYAKINA I T， GUSKOVA T A， et al. Sensitivity of various influenza virus strains to arbidol. Influence of arbidol combination with different antiviral drugs on reproduction of influenza virus A ［J］.Ter Arkh，2005， 77(8):84-88.
［2］ L′VOV O K, BURTSEVA E I, PRILIPOV A G, et al. The 24 May， 2009 isolation of the first A/IIV-Moscow/01/2009 (H1N1)swl strain similar to swine A(H1N1) influenza virus from the first Moscow case detected on May 21， 2009， and its deposit in the state collection of viruses (SCV No. 2452 dated May 24， 2009)［J］. Vopr Virusol， 2009， 54(5):10-14.
［3］ JIN Y Q， SUN F， ZHANG S Q， et al. Study about pharmacodynamics of arbidol hydrochloride on influenza virus infection［J］. Chin Pharmacol Bull (中国药理学通报)，2004，20(10):1150-1152.
［4］ IRINA A L， RUPERT J R， YURY S B， et al. Characteristics of arbidol-resistant mutants of influenza virus: Implications for the mechanism of anti-influenza action of arbidol［J］.Antivir Res， 2009， 81（2）:132-140.
［5］ BORISKIN Y S， PéCHEU E I， POLYAK S J. Arbidol: a broad-spectrum antiviral that inhibits acute and chronic HCV infection［J］.Virol J， 2006， 3:56. doi: 10.1186/1743-422X-3-56.
［6］ PCHEU E I， LAVILLETTE D， ALCARAS F， et al. Biochemical mechanism of hepatitis C virus inhibition by the broad-spectrum antiviral arbidol［J］.Biochemistry， 2007， 46(20): 6050-6059.
［7］ DENG H Y, LUO F, SHI L Q, et al. In vitro antiviral activity of arbidol hydrochloride upon Hantavirus［J］. Chin Pharm J(中国药学杂志)， 2009，44(3): 183-186.
［8］ DENG H Y， LUO F， SHI L Q， et al. Efficacy of arbidol on lethal hantaan virus infections in suckling mice and in vitro［J］. Acta Pharmacol Sin（中国药理学报）， 2009， 30（7）:1015-1024.
［9］ ZHONG Q， YANG Z Q， LIU Y Y， et al. Antiviral activity of arbidol against coxsackie virus B5 in vitro and in vivo［J］.Arch Virol， 2009，154（4）:601-607.
［10］ SILIN D S， LYUBOMSKA O V， ERSHOV F I， et al. Synthetic and natural immunomodulators acting as interferon inducers［J］. Curr Pharm Des， 2009，15（11）：1238-1247.
［11］ ZHOU P， JIANG J Y， CHEN S Y， et al. Immunity modulating of arbidol hydrochloride in Mice［J］.Her Med(医药导报)， 2005，24 (11）:989-991.
［12］ SEMENENKO T A， SEIKOVA E P， GOTVYANSKAYA T P， et al. Characteristics of the immune status in specific and nonspecific prophylaxis of influenza in elderly persons［J］. Zh Mikrobiol Epidemiol Immunobiol， 2005，Nov-Dec（6）: 24-28.
［13］ WANG M Z， CAI B Q， LI L Y， et al. Efficacy and safety of arbidol in treatment of naturally acquired influenza［J］.Acta Acad Med Sin(中国医学科学院学报)， 2004，26(3):289-293.
［14］ LIU M Y， WANG S， YAO W F， et al. Pharmacokinetic properties and bioequivalence of two formulations of Arbidol: an open-label， single-dose， randomized-sequence， two-period crossover study in healthy Chinese male volunteers［J］.Clin Ther， 2009， 31(4): 784-792.
［15］ WANG Y Y， CHEN X Y， LI Q， et al. Metabolite identification of arbidol in human urine by the study of CID fragmentation pathways using HPLC coupled with ion trap mass spectrometry［J］.J Mass Spectrom，2008， 43（8）: 1099-1110.
［16］ VASIL'EV A N， GATICH R Z， KOLOBUKHINA L V， et al. Viferon efficacy in influenza in adult patients［J］. Antibiot Khimioter， 2009， 54(3-4):21-25.
［17］ LIU H B， QU W X， LI S Q， et al. Multicenter randomized double blind parallel clinical trail of arbidol hydrochloride tablet in treatment of naturally acquired influenza［J］.Chin J Clin Pharmacol（中国临床药理学杂志），2006，22（6）：403-405.
［18］ SHUSTER A M， SHUMILOV V I， SHEVTSOV V A， et al. Arbidol used in the prophylaxis of acute respiratory viral infections and their complications in servicemen［J］. Voen Med Zh， 2004， 325(9):44-45.
［19］ DRINEVSKY V P， OSIDAK L V， NATSINA V K， et al. Chemotherapeutics in the therapy of influenza and other viral respiratory infections in children［J］. Antibiot Khimioter，1998，43(9):29-34.
［20］ Development of antiinfluenza A drug with independent intellectual property rights of China［J］. China Med Her(中国医药导报)，2009，6（24）：1.